Growth hormone therapy does not induce cancer

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 10, 2006, Pages 532-533

  Sheppard, Michael C ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BRAIN TUMOR; BREAST CANCER; CANCER RISK; CHILDHOOD CANCER; COLON ADENOMA; COLORECTAL CANCER; GROWTH HORMONE DEFICIENCY; HODGKIN DISEASE; HORMONAL THERAPY; HUMAN; LEUKEMIA; MALIGNANT NEOPLASTIC DISEASE; MENINGIOMA; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY;

CLINICAL TRIALS; DWARFISM, PITUITARY; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; RISK FACTORS;

EID: 33749541926     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0294     Document Type: Short Survey

References (10)

1. Renehan AG et al. (2004) Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363: 1346-1353
2. Orme SM et al. (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab 83: 2730-2734
3. Ayuk J et al. (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 89: 1613-1617
4. Melmed S (2001) Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 86: 2929-2934
5. Swerdlow AJ et al. (2002) Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-1985: a cohort study. Lancet 360: 273-277
6. Swerdlow AJ et al. (2000). Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab 85: 4444-4449
7. Leung W et al. (2002) Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 20: 2959-2964
8. Sklar CA et al. (2002) Risk of disease recurrence and second neoplasm in survivors of childhood cancer treated with growth hormone: A report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87: 3136-3141
9. Jostel A et al. (2005) Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors. Clin Endocrinol (Oxf) 62: 698-705
10. Monson JP (2003) Long-term experience with GH replacement therapy: efficacy and safety. Eur J Endocrinol 148 (Suppl 2): S9-S14